Technology & innovation

This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.

Microsoft logo, for article on fusion power purchase agreement

Helion announces world’s first fusion energy purchase agreement with Microsoft

By / / Good News For Humankind

Fusion energy just took a big step from lab to grid: Helion Energy has signed the world’s first commercial fusion power purchase agreement, promising Microsoft at least 50 megawatts of electricity from a plant targeted to come online in 2028. That timeline is roughly a decade ahead of most expert projections for commercial fusion. Helion has already built six prototypes and reached the 100-million-degree plasma temperatures considered necessary for self-sustaining reactions, with Constellation handling the grid-side logistics. The engineering road ahead is steep, and nothing is guaranteed. But moving fusion from research aspiration onto a real buyer’s procurement list is a meaningful shift, hinting at a future where zero-carbon baseload power becomes a practical piece of the climate puzzle.

Viruses under microscope, for article on RSV vaccine approval

U.S. FDA approves first-ever vaccine for RSV

By / / Good News For Humankind

Pfizer’s RSV vaccine ABRYSVO just became the first licensed option for at-risk adults as young as 18, closing a long-standing protection gap for younger people living with chronic conditions. About one in ten U.S. adults aged 18 to 49 has a condition like diabetes, asthma, or heart failure that raises their risk of severe RSV illness — and until now, they had nothing. The vaccine targets RSV’s prefusion F protein, a breakthrough that finally unlocked effective design after decades of frustrating research. With approvals now spanning pregnant individuals, older adults, and at-risk younger adults, ABRYSVO marks a quiet but powerful turning point in a field that struggled for half a century — a reminder that patient science eventually delivers real protection to real people.